公开(公告)号：US20160067495A1

公开(公告)日：2016-03-10

申请号：US14481379

申请日：2014-09-09

Applicant: Medtronic, Inc.

Inventor： Ashutosh Chaturvedi ,  Siddharth Dani ,  Timothy J. Denison ,  William F. Kaemmerer ,  Shahram Malekkhosravi ,  Eric J. Panken ,  Brandon Zingsheim

IPC: A61N1/36 ,  G06F19/00

Abstract: In some examples, a processor of a system evaluates a therapy program based on a score determined based on a volume of tissue expected to be activated (“VTA”) by therapy delivery according to the therapy program. The score may be determined using an efficacy map comprising a plurality of voxels that are each assigned a value. In some examples, the efficacy map is selected from a plurality of stored efficacy maps based on a patient condition, one or more patient symptoms, or both the patient condition and one or more patient symptoms. In addition, in some examples, voxels of the efficacy map are assigned respective values that are associated with a clinical rating scale.

Abstract translation: 在一些示例中，系统的处理器基于通过根据治疗程序的治疗递送基于预期被激活的组织体积（“VTA”）确定的评分来评估治疗程序。 可以使用包括多个体素的功效图来确定分数，每个体素分配一个值。 在一些示例中，基于患者状况，一个或多个患者症状或患者状况和一个或多个患者症状，从多个存储的效能图中选择功效图。 此外，在一些示例中，功效图的体素被分配与临床评级量表相关联的各自的值。

公开(公告)号：US10583293B2

公开(公告)日：2020-03-10

申请号：US14481379

申请日：2014-09-09

Applicant: Medtronic, Inc.

Inventor： Ashutosh Chaturvedi ,  Siddharth Dani ,  Timothy J. Denison ,  William F. Kaemmerer ,  Shahram Malekkhosravi ,  Eric J. Panken ,  Brandon Zingsheim

IPC: A61B5/0478 ,  G16H50/50 ,  G16H50/30 ,  A61N1/36 ,  A61N1/372 ,  G06F19/00 ,  A61B5/00 ,  A61B5/04

Abstract: In some examples, a processor of a system evaluates a therapy program based on a score determined based on a volume of tissue expected to be activated (“VTA”) by therapy delivery according to the therapy program. The score may be determined using an efficacy map comprising a plurality of voxels that are each assigned a value. In some examples, the efficacy map is selected from a plurality of stored efficacy maps based on a patient condition, one or more patient symptoms, or both the patient condition and one or more patient symptoms. In addition, in some examples, voxels of the efficacy map are assigned respective values that are associated with a clinical rating scale.

公开(公告)号：US11648398B2

公开(公告)日：2023-05-16

申请号：US16774418

申请日：2020-01-28

Applicant: Medtronic, Inc.

Inventor： Ashutosh Chaturvedi ,  Siddharth Dani ,  Timothy J. Denison ,  William F. Kaemmerer ,  Shahram Malekkhosravi ,  Eric J. Panken ,  Brandon Zingsheim

IPC: G16H50/50 ,  G16H20/40 ,  G16H20/30 ,  A61B5/291 ,  G16H50/30 ,  A61B5/24 ,  A61N1/36 ,  A61N1/372 ,  A61B5/00

CPC classification number: A61N1/36128 ,  A61B5/291 ,  A61B5/4064 ,  A61B5/4833 ,  A61N1/3605 ,  A61N1/36067 ,  A61N1/36082 ,  A61N1/36096 ,  A61N1/36132 ,  A61N1/36182 ,  A61N1/37247 ,  G16H20/30 ,  G16H20/40 ,  G16H50/50 ,  A61B5/24 ,  A61B5/4076 ,  G16H50/30

Abstract: In some examples, a processor of a system evaluates a therapy program based on a score determined based on a volume of tissue expected to be activated (“VTA”) by therapy delivery according to the therapy program. The score may be determined using an efficacy map comprising a plurality of voxels that are each assigned a value. In some examples, the efficacy map is selected from a plurality of stored efficacy maps based on a patient condition, one or more patient symptoms, or both the patient condition and one or more patient symptoms. In addition, in some examples, voxels of the efficacy map are assigned respective values that are associated with a clinical rating scale.

公开(公告)号：US20200164212A1

公开(公告)日：2020-05-28

申请号：US16774418

申请日：2020-01-28

Applicant: Medtronic, Inc.

Inventor： Ashutosh Chaturvedi ,  Siddharth Dani ,  Timothy J. Denison ,  William F. Kaemmerer ,  Shahram Malekkhosravi ,  Eric J. Panken ,  Brandon Zingsheim

IPC: A61N1/36 ,  G16H50/50 ,  A61B5/00 ,  A61B5/0478 ,  A61N1/372

Abstract: In some examples, a processor of a system evaluates a therapy program based on a score determined based on a volume of tissue expected to be activated (“VTA”) by therapy delivery according to the therapy program. The score may be determined using an efficacy map comprising a plurality of voxels that are each assigned a value. In some examples, the efficacy map is selected from a plurality of stored efficacy maps based on a patient condition, one or more patient symptoms, or both the patient condition and one or more patient symptoms. In addition, in some examples, voxels of the efficacy map are assigned respective values that are associated with a clinical rating scale.